Target Identification Identify relevant disease targets during the early stages of discovery for new biotherapeutics. Avoid latent failures downstream by thorough validation of each target relevance in human disease through a combination of in vitro and in vivo approaches.
Cloning and Expression We offer a range of microfluidic, ELISA-alternative, imaging, informatics, detection and automation solutions that simplify workflow and improve the quality of data generated at every stage in the cloning and expression process;
Safety and Preclinical Accurately quantify ant-drug antibodies (ADA) and pharmacokinetics (PK) / pharmacodynamics (PD) through high-quality, reproducible test data. Whether your research involves monoclonal antibodies (mAb) or proteins and peptides, our wide portfolio of immunogenicity, neutralizing antibody (NAb) and PD/PK testing solutions can streamline your workflow.
We are always ready to help you and answer your questions